{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:12:55Z","timestamp":1793412775532,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2017,11,16]],"date-time":"2017-11-16T00:00:00Z","timestamp":1510790400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s12325-017-0635-3","type":"journal-article","created":{"date-parts":[[2017,11,16]],"date-time":"2017-11-16T01:42:15Z","timestamp":1510796535000},"page":"2558-2565","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Update on the Treatment of Uveitis in Patients with Juvenile Idiopathic Arthritis: A Review"],"prefix":"10.1007","volume":"34","author":[{"given":"Ioannis","family":"Asproudis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6623-8503","authenticated-orcid":false,"given":"Andreas","family":"Katsanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Kozeis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Tantou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasios G.","family":"Konstas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,16]]},"reference":[{"key":"635_CR1","first-page":"243","volume":"48","author":"J Ohm","year":"1910","unstructured":"Ohm J. Bandfoermige Hornhauttruebung bei einem neunjaehrigen Maedchen und ihre Behandlung mit subconjunctivalen Jodkaliumeinspritzungen. Klin Monatsbl Augenheilkd. 1910;48:243\u20136.","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"635_CR2","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/ICU.0b013e32833eab83","volume":"21","author":"Y Qian","year":"2010","unstructured":"Qian Y, Acharya NR. Juvenile idiopathic arthritis-associated uveitis. Curr Opin Ophthalmol. 2010;21:468\u201372.","journal-title":"Curr Opin Ophthalmol"},{"key":"635_CR3","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nrrheum.2015.20","volume":"11","author":"ES Sen","year":"2015","unstructured":"Sen ES, Dick AD, Ramanan AV. Uveitis associated with juvenile idiopathic arthritis. Nat Rev Rheumatol. 2015;11:338\u201348.","journal-title":"Nat Rev Rheumatol"},{"key":"635_CR4","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s12016-014-8436-9","volume":"49","author":"I Foeldvari","year":"2015","unstructured":"Foeldvari I. Ocular involvement in juvenile idiopathic arthritis: classification and treatment. Clin Rev Allergy Immunol. 2015;49:271\u20137.","journal-title":"Clin Rev Allergy Immunol"},{"key":"635_CR5","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000438758","volume":"54","author":"JM Wells","year":"2015","unstructured":"Wells JM, Smith JR. Uveitis in juvenile idiopathic arthritis: recent therapeutic advances. Ophthalmic Res. 2015;54:124\u20137.","journal-title":"Ophthalmic Res"},{"key":"635_CR6","first-page":"1991","volume":"25","author":"RE Petty","year":"1998","unstructured":"Petty RE, Southwood TR, Baum J, et al. Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. J Rheumatol. 1998;25:1991\u20134.","journal-title":"J Rheumatol"},{"key":"635_CR7","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0039-6257(03)00084-5","volume":"48","author":"K Kotaniemi","year":"2003","unstructured":"Kotaniemi K, Savolainen A, Karma A, Aho K. Recent advances in uveitis of juvenile idiopathic arthritis. Surv Ophthalmol. 2003;48:489\u2013502.","journal-title":"Surv Ophthalmol"},{"key":"635_CR8","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0161-6420(97)30329-7","volume":"104","author":"MR Dana","year":"1997","unstructured":"Dana MR, Merayo-Lloves J, Schaumberg DA, Foster CS. Visual outcomes prognosticators in juvenile rheumatoid arthritis-associated uveitis. Ophthalmology. 1997;104:236\u201344.","journal-title":"Ophthalmology"},{"key":"635_CR9","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1136\/bjo.73.3.225","volume":"73","author":"JJ Kanski","year":"1989","unstructured":"Kanski JJ. Screening for uveitis in juvenile chronic arthritis. Br J Ophthalmol. 1989;73:225\u20138.","journal-title":"Br J Ophthalmol"},{"key":"635_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/09273940801899822","volume":"16","author":"J Deschenes","year":"2008","unstructured":"Deschenes J, Murray PI, Rao NA, Nussenblatt RB, International Uveitis Study Group. International Uveitis Study Group (IUSG): clinical classification of uveitis. Ocul Immunol Inflamm. 2008;16:1\u20132.","journal-title":"Ocul Immunol Inflamm"},{"key":"635_CR11","first-page":"367","volume":"17","author":"G\u00e4re B Andersson","year":"1999","unstructured":"Andersson G\u00e4re B. Juvenile arthritis\u2014who gets it, where and when? A review of current data on incidence and prevalence. Clin Exp Rheumatol. 1999;17:367\u201374.","journal-title":"Clin Exp Rheumatol"},{"key":"635_CR12","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12969-016-0088-2","volume":"14","author":"SL Clarke","year":"2016","unstructured":"Clarke SL, Sen ES, Ramanan AV. Juvenile idiopathic arthritis-associated uveitis. Pediatr Rheumatol Online J. 2016;14:27.","journal-title":"Pediatr Rheumatol Online J"},{"key":"635_CR13","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s00296-015-3231-3","volume":"35","author":"R Bou","year":"2015","unstructured":"Bou R, Ad\u00e1n A, Borr\u00e1s F, et al. Clinical management algorithm of uveitis associated with juvenile idiopathic arthritis: interdisciplinary panel consensus. Rheumatol Int. 2015;35:777\u201385.","journal-title":"Rheumatol Int"},{"key":"635_CR14","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0002-9394(14)72008-2","volume":"122","author":"CS Foster","year":"1996","unstructured":"Foster CS, Alter G, DeBarge LR, et al. Efficacy and safety of rimexolone 1% ophthalmic suspension vs 1% prednisolone acetate in the treatment of uveitis. Am J Ophthalmol. 1996;122:171\u201382.","journal-title":"Am J Ophthalmol"},{"key":"635_CR15","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.autrev.2010.05.017","volume":"9","author":"G Simonini","year":"2010","unstructured":"Simonini G, Cantarini L, Bresci C, Lorusso M, Galeazzi M, Cimaz R. Current therapeutic approaches to autoimmune chronic uveitis in children. Autoimmun Rev. 2010;9:674\u201383.","journal-title":"Autoimmun Rev"},{"key":"635_CR16","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1016\/j.ophtha.2012.07.025","volume":"119","author":"SR Taylor","year":"2012","unstructured":"Taylor SR, Tomkins-Netzer O, Joshi L, Morarji J, McLoone E, Lightman S. Dexamethasone implant in pediatric uveitis. Ophthalmology. 2012;119:2412.","journal-title":"Ophthalmology"},{"key":"635_CR17","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1007\/s00417-015-3124-x","volume":"253","author":"R Sella","year":"2015","unstructured":"Sella R, Oray M, Friling R, Umar L, Tugal-Tutkun I, Kramer M. Dexamethasone intravitreal implant (Ozurdex) for pediatric uveitis. Graefes Arch Clin Exp Ophthalmol. 2015;253:1777\u201382.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"635_CR18","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10792-016-0265-9","volume":"37","author":"F Pichi","year":"2017","unstructured":"Pichi F, Nucci P, Baynes K, Lowder CY, Srivastava SK. Sustained-release dexamethasone intravitreal implant in juvenile idiopathic arthritis-related uveitis. Int Ophthalmol. 2017;37:221\u20138.","journal-title":"Int Ophthalmol"},{"key":"635_CR19","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0161-6420(96)30683-0","volume":"103","author":"AT Vitale","year":"1996","unstructured":"Vitale AT, Rodriguez A, Foster CS. Low-dose cyclosporin A therapy in treating chronic, noninfectious uveitis. Ophthalmology. 1996;103:365\u201373.","journal-title":"Ophthalmology"},{"key":"635_CR20","first-page":"362","volume":"32","author":"I Foeldvari","year":"2005","unstructured":"Foeldvari I, Wierk A. Methotrexate is an effective treatment for chronic uveitis associated with juvenile idiopathic arthritis. J Rheumatol. 2005;32:362\u20135.","journal-title":"J Rheumatol"},{"key":"635_CR21","first-page":"867","volume":"135","author":"GN Holland","year":"2003","unstructured":"Holland GN, Stiehm ER. Special considerations in the evaluation and management of uveitis in children. J Ophthalmol. 2003;135:867\u201378.","journal-title":"J Ophthalmol"},{"key":"635_CR22","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/00055735-200312000-00013","volume":"14","author":"CS Foster","year":"2003","unstructured":"Foster CS. Diagnosis and treatment of juvenile idiopathic arthritis-associated uveitis. Curr Opin Ophthalmol. 2003;14:395\u20138.","journal-title":"Curr Opin Ophthalmol"},{"key":"635_CR23","doi-asserted-by":"crossref","first-page":"41","DOI":"10.12703\/P6-41","volume":"6","author":"BA Wentworth","year":"2014","unstructured":"Wentworth BA, Freitas-Neto CA, Foster CS. Management of pediatric uveitis. F1000Prime Rep. 2014;6:41.","journal-title":"F1000Prime Rep"},{"key":"635_CR24","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S0002-9394(03)00104-1","volume":"135","author":"RE Petty","year":"2003","unstructured":"Petty RE, Smith JR, Rosenbaum JT. Arthritis and uveitis in children: a pediatric rheumatology perspective. Am J Ophthalmol. 2003;135:879\u201384.","journal-title":"Am J Ophthalmol"},{"key":"635_CR25","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/01.icu.0000177414.79030.32","volume":"16","author":"GA Levy-Clarke","year":"2005","unstructured":"Levy-Clarke GA, Nussenblatt RB, Smith JA. Management of chronic pediatric uveitis. Cur Opin Ophthalmol. 2005;16:281\u20138.","journal-title":"Cur Opin Ophthalmol"},{"key":"635_CR26","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1093\/rheumatology\/kes186","volume":"52","author":"G Simonini","year":"2013","unstructured":"Simonini G, Paudyal P, Jones GT, Cimaz R, Macfarlane GJ. Current evidence of methotrexate efficacy in childhood chronic uveitis: a systematic review and meta-analysis approach. Rheumatology (Oxford). 2013;52:825\u201331.","journal-title":"Rheumatology (Oxford)"},{"key":"635_CR27","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ajo.2010.08.021","volume":"151","author":"V Kalinina Ayuso","year":"2011","unstructured":"Kalinina Ayuso V, Rothova A, de Boer JH. Relapse rate of uveitis post-methotrexate treatment in juvenile idiopathic arthritis. Am J Ophthalmol. 2011;151:217\u201322.","journal-title":"Am J Ophthalmol"},{"key":"635_CR28","first-page":"714","volume":"34","author":"MM Kostik","year":"2016","unstructured":"Kostik MM, Gaidar EV, Hynnes AY, et al. Methotrexate treatment may prevent uveitis onset in patients with juvenile idiopathic arthritis: experiences and subgroup analysis in a cohort with frequent methotrexate use. Clin Exp Rheumatol. 2016;34:714\u20138.","journal-title":"Clin Exp Rheumatol"},{"key":"635_CR29","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S0161-6420(01)00576-0","volume":"108","author":"CM Samson","year":"2001","unstructured":"Samson CM, Waheed N, Baltatzis S, Foster CS. Methotrexate therapy for chronic noninfectious uveitis: analysis of a case series of 160 patients. Ophthalmology. 2001;108:1134\u20139.","journal-title":"Ophthalmology"},{"key":"635_CR30","first-page":"362","volume":"32","author":"I Foeldvari","year":"2005","unstructured":"Foeldvari I, Wierk A. Methotrexate is an effective treatment for chronic uveitis associated with juvenile idiopathic arthritis. J Rheumatol. 2005;32:362\u20135.","journal-title":"J Rheumatol"},{"key":"635_CR31","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/acr.22649","volume":"68","author":"C Tappeiner","year":"2016","unstructured":"Tappeiner C, Schenck S, Niewerth M, Heiligenhaus A, Minden K, Klotsche J. Impact of antiinflammatory treatment on the onset of uveitis in juvenile idiopathic arthritis: longitudinal analysis from a nationwide pediatric rheumatology database. Arthritis Care Res (Hoboken). 2016;68:46\u201354.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"635_CR32","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1038\/eye.2008.174","volume":"23","author":"C Tappeiner","year":"2009","unstructured":"Tappeiner C, Roesel M, Heinz C, Michels H, Ganser G, Heiligenhaus A. Limited value of cyclosporine A for the treatment of patients with uveitis associated with juvenile idiopathic arthritis. Eye (Lond). 2009;23:1192\u20138.","journal-title":"Eye (Lond)"},{"key":"635_CR33","doi-asserted-by":"crossref","first-page":"38","DOI":"10.2174\/1871528111312010006","volume":"12","author":"R Galego-Pinazo","year":"2013","unstructured":"Galego-Pinazo R, Dolz-Marco R, Martinez-Castillo S, Arevalo JF, Diaz-Llopis M. Update on the principles and novel local and systemic therapies for the treatment of non-infectious uveitis. Inflamm Allergy Drug Targets. 2013;12:38\u201345.","journal-title":"Inflamm Allergy Drug Targets"},{"key":"635_CR34","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3109\/09273948.2015.1077976","volume":"24","author":"RM Amin","year":"2016","unstructured":"Amin RM, Miserocchi E, Thorne JE, Hornbeak D, Jabs DA, Zierhut M. Treatment options for juvenile idiopathic arthritis (JIA) associated uveitis. Ocul Immunol Inflamm. 2016;24:81\u201390.","journal-title":"Ocul Immunol Inflamm"},{"key":"635_CR35","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3109\/03009742.2015.1013983","volume":"44","author":"J Bichler","year":"2015","unstructured":"Bichler J, Benseler SM, Krumrey-Langkammerer M, Haas JP, H\u00fcgle B. Leflunomide is associated with a higher flare rate compared to methotrexate in the treatment of chronic uveitis in juvenile idiopathic arthritis. Scand J Rheumatol. 2015;44:280\u20133.","journal-title":"Scand J Rheumatol"},{"issue":"6","key":"635_CR36","first-page":"92","volume":"112","author":"A Heiligenhaus","year":"2015","unstructured":"Heiligenhaus A, Minden K, F\u00f6ll D, Pleyer U. Uveitis in juvenile idiopathic arthritis. Dtsch Arztebl Int. 2015;112(6):92\u2013100.","journal-title":"Dtsch Arztebl Int"},{"key":"635_CR37","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jpeds.2006.04.058","volume":"149","author":"LB Vazquez-Cobian","year":"2006","unstructured":"Vazquez-Cobian LB, Flynn T, Lehman JA. Adalimumab therapy for childhood uveitis. J Pediatr. 2006;149:572\u20135.","journal-title":"J Pediatr"},{"key":"635_CR38","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1136\/bjo.2006.103721","volume":"91","author":"S Biester","year":"2007","unstructured":"Biester S, Deuter C, Michels H, et al. Adalimumab in the therapy of uveitis in childhood. Br J Ophthalmol. 2007;91:319\u201324.","journal-title":"Br J Ophthalmol"},{"key":"635_CR39","doi-asserted-by":"crossref","first-page":"560632","DOI":"10.1155\/2013\/560632","volume":"2013","author":"C Garc\u00eda-De-Vicu\u00f1a","year":"2013","unstructured":"Garc\u00eda-De-Vicu\u00f1a C, D\u00edaz-Llopis M, Salom D, et al. Usefulness of adalimumab in the treatment of refractory uveitis associated with juvenile idiopathic arthritis. Mediat Inflamm. 2013;2013:560632.","journal-title":"Mediat Inflamm"},{"key":"635_CR40","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.3899\/jrheum.130133","volume":"40","author":"A Tambralli","year":"2013","unstructured":"Tambralli A, Beukelman T, Weiser P, Atkinson TP, Cron RQ, Stoll ML. High doses of infliximab in the management of juvenile idiopathic arthritis. J Rheumatol. 2013;40:1749\u201355.","journal-title":"J Rheumatol"},{"key":"635_CR41","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1002\/art.27431","volume":"62","author":"N Ruperto","year":"2010","unstructured":"Ruperto N, Lovell DJ, Quartier P, Paediatric Rheumatology International Trials Organization and the Pediatric Rheumatology Collaborative Study Group, et al. Long-term safety and efficacy of abatacept in children with juvenile idiopathic arthritis. Arthritis Rheum. 2010;62:1792\u2013802.","journal-title":"Arthritis Rheum"},{"key":"635_CR42","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.3899\/jrheum.151389","volume":"43","author":"C Birolo","year":"2016","unstructured":"Birolo C, Zannin ME, Arsenyeva S, et al. Comparable efficacy of Abatacept used as first-line or second-line biological agent for severe juvenile idiopathic arthritis-related uveitis. J Rheumatol. 2016;43:2068\u201373.","journal-title":"J Rheumatol"},{"key":"635_CR43","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.ophtha.2013.09.048","volume":"121","author":"G Levy-Clarke","year":"2013","unstructured":"Levy-Clarke G, Jabs DA, Read RW, Rosenbaum JT, Vitale A, Vangelder RN. Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders. Ophthalmology. 2013;121:785\u201396.","journal-title":"Ophthalmology"},{"key":"635_CR44","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1093\/rheumatology\/keh658","volume":"44","author":"H Schmeling","year":"2005","unstructured":"Schmeling H, Horneff G. Etanercept and uveitis in patients with juvenile idiopathic arthritis. Rheumatology (Oxford). 2005;44:1008\u201311.","journal-title":"Rheumatology (Oxford)"},{"key":"635_CR45","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1136\/bjophthalmol-2015-306790","volume":"100","author":"E Miserocchi","year":"2016","unstructured":"Miserocchi E, Modorati G, Berchicci L, Pontikaki I, Meroni P, Gerloni V. Long-term treatment with rituximab in severe juvenile idiopathic arthritis-associated uveitis. Br J Ophthalmol. 2016;100:782\u20136.","journal-title":"Br J Ophthalmol"},{"key":"635_CR46","first-page":"46","volume":"68","author":"C Tappeiner","year":"2016","unstructured":"Tappeiner C, Mesquida M, Ad\u00e1n A, et al. Evidence for tocilizumab as a treatment option in refractory uveitis associated with juvenile idiopathic arthritis. J Rheumatol. 2016;68:46\u201354.","journal-title":"J Rheumatol"},{"key":"635_CR47","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/art.39940","volume":"69","author":"V Calvo-R\u00edo","year":"2017","unstructured":"Calvo-R\u00edo V, Santos-G\u00f3mez M, Calvo I, et al. Anti-interleukin-6 receptor tocilizumab for severe juvenile idiopathic arthritis-associated uveitis refractory to anti-tumor necrosis factor therapy: a multicenter study of twenty-five patients. Arthritis Rheumatol. 2017;69:668\u201375.","journal-title":"Arthritis Rheumatol"},{"key":"635_CR48","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1136\/bjo.84.7.791","volume":"84","author":"A Lundvall","year":"2000","unstructured":"Lundvall A, Zetterstr\u00f6m C. Cataract extraction and intraocular lens implantation in children with uveitis. Br J Ophthalmol. 2000;84:791\u20133.","journal-title":"Br J Ophthalmol"},{"key":"635_CR49","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0002-9394(14)72007-0","volume":"122","author":"LE Probst","year":"1996","unstructured":"Probst LE, Holland EJ. Intraocular lens implantation in patients with juvenile rheumatoid arthritis. Am J Ophthalmol. 1996;122:161\u201370.","journal-title":"Am J Ophthalmol"},{"key":"635_CR50","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1001\/archopht.1997.01100160423005","volume":"115","author":"J V\u00e4lim\u00e4ki","year":"1997","unstructured":"V\u00e4lim\u00e4ki J, Airaksinen PJ, Tuulonen A. Molteno implantation for secondary glaucoma in juvenile rheumatoid arthritis. Arch Ophthalmol. 1997;115:1253\u20136.","journal-title":"Arch Ophthalmol"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12325-017-0635-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-017-0635-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-017-0635-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,11,30]],"date-time":"2017-11-30T03:58:36Z","timestamp":1512014316000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12325-017-0635-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,16]]},"references-count":50,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["635"],"URL":"https:\/\/doi.org\/10.1007\/s12325-017-0635-3","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,16]]}}}